Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in ratsPharmacology Biochemistry and Behavior · 2026-10-01Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study.Psychedelic medicine (New Rochelle, N.Y.) · 2026-09-01Balancing safety and access in Oregon’s psilocybin servicesInternational Journal of Drug Policy · 2026-09-01Efficacy and Safety of Psychedelic Microdosing on Psychological Outcomes in Healthy Adults: A Systematic Review and Meta-analysis.CNS drugs · 2026-08-13Exploring the In Vitro Effect of Psilocybin on the Composition and Metabolic Activity of Gut Microbiota in Individuals with Severe AnxietyDrugs and Drug Candidates · 2026-08-12The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisJournal of Affective Disorders · 2026-08-01Convergent neuroimmune signaling underlying rapid antidepressant response to ketamine and psychedelics.Molecular psychiatry · 2026-07-28No evidence for deleterious effects of psilocybin and MDMA on working memory or related neurophysiological activity in a non-clinical population: An uncontrolled exploratory studyJournal of Psychopharmacology · 2026-07-23Psilocybin produces amplified acute responses and sex-specific long-term increases in sensorimotor gating in the mGlu5 knockout mouse model of schizophreniaNeuropsychopharmacology · 2026-07-18Psilocybin therapy for adult females with anorexia nervosa: pilot studyThe British Journal of Psychiatry · 2026-07-08The need for another tool: Australian healthcare professionals on the use of psilocybin for existential distress in people with cancerBMC Medicine · 2026-07-06The Australia story: Current status and future challenges for the clinical applications of psychedelics.British journal of pharmacology · 2026-07-01Recreational drug poisonings reported to six European poison centres from 2021 to 2024.Clinical toxicology (Philadelphia, Pa.) · 2026-07-01Psychedelic Use, Microdosing, Motives, and Information and Product Sources Among Young Adults in the United States.Journal of psychoactive drugs · 2026-06-19Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depressionJournal of Affective Disorders · 2026-06-01Psilocybin restores behavioral and neuroplastic deficits induced by chronic stress in ratsProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2026-06-01Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorderTranslational Psychiatry · 2026-05-26Neural correlates of insight on psilocybin: a within-subjects, healthy volunteer studyJoCN Forum · 2026-05-08Human brain changes after first psilocybin useNature Communications · 2026-05-05356. Psilocybin Therapy is Associated With Decreases in Markers of Mitochondrial Stress and Inflammation in an Open-Label Clinical Trial of Parkinson’s DiseaseBiological Psychiatry · 2026-05-01C29-12 Psilocybin Treatment Could Improve Outcomes for Age-associated Lung DiseasesAmerican Journal of Respiratory and Critical Care Medicine · 2026-05-01The effects of psilocybin on time perception in humans: A comparative analysis of subjective and objective measures.Journal of psychopharmacology (Oxford, England) · 2026-05-01A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive-compulsive disorderJournal of Psychopharmacology · 2026-05-01A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experienceFrontiers in Public Health · 2026-04-14Observing the mind under psychedelics: conceptual metaphors used following four once-weekly macrodoses of psilocybinPhilosophical Psychology · 2026-04-10Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical ImplicationsFocus · 2026-04-01Effects of psilocybin and chronic mild stress on microglial activation in rat spinal cord: an ex vivo analysis.Pharmacological reports: PR · 2026-04-01An international mega-analysis of psychedelic drug effects on brain circuit function.Nature medicine · 2026-04-01Psychedelics in NHS services: exploring a model for real-world implementation of psilocybinThe British Journal of Psychiatry · 2026-03-30Unlocking 'stuckness' and catalysing change: A qualitative study of clinician and service leader perspectives on psychedelic-assisted therapy for substance use and mental health problems.Addiction (Abingdon, England) · 2026-03-30Psilocybin in Neuropsychiatric Disorders: Seeking Valuable Evidence in History, Pure Science, Clinical Trials and Real-World Data (RWD)Brain Sciences · 2026-03-26A fungus among us: investigating queensland’s largest magic mushroom growing operationAustralian Journal of Forensic Sciences · 2026-03-16Behavioural investigations of psilocybin in non-human animals 1962-2021: A scoping reviewJournal of Psychedelic Studies · 2026-03-09Engineering artificial biosynthetic pathways for efficient microbial production of psilocybin and psilocinMetabolic Engineering · 2026-03-01Sense-Making Around Psilocybin in UK Women Experiencing Cancer-Related Existential Distress: An Interpretative Phenomenological Analysis.Qualitative health research · 2026-02-17Psychedelics in psychiatric treatment: a literature reviewQuality in Sport · 2026-01-26The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidenceZenodo (CERN European Organization for Nuclear Research) · 2026-01-26Sense-making around psilocybin in UK women experiencing cancer-related existential distress: An Interpretative Phenomenological AnalysisResearch Explorer (The University of Manchester) · 2026-01-09Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trial.Progress in neuro-psychopharmacology & biological psychiatry · 2025-12-20Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology · 2025-12-01Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment.EClinicalMedicine · 2025-12-01Long-term outcomes of single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - 12-month data from an open-label pilot study.Journal of affective disorders · 2025-11-15Correction: Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenologyTranslational Psychiatry · 2025-11-12Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidencePsychedelics. · 2025-10-27Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases.Schizophrenia bulletin · 2025-10-06Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l'étude.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2025-10-01Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study.Comprehensive psychiatry · 2025-10-01Effects of serotonergic psychedelics on synaptogenesis and immediate early genes expression - comparison with ketamine, fluoxetine and lithium.Journal of psychopharmacology (Oxford, England) · 2025-09-01Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression.Journal of psychopharmacology (Oxford, England) · 2025-09-01Cross-Species Evidence for Psilocin-Induced Visual Distortions: Apparent Motion Is Perceived by Both Humans and RatsBiological Psychiatry Global Open Science · 2025-09-01A lexicon for psychedelic research and treatmentDrug Science Policy and Law · 2025-08-31Neurocognitive effects of psilocybin: A systematic and comprehensive review of neuroimaging studies in humans.Neuroscience and biobehavioral reviews · 2025-08-01Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians' Concerns.The Journal of law, medicine & ethics: a journal of the American Society of Law, Medicine & Ethics · 2025-07-31Exploring the Frontiers of Psychedelics: A New Chromatographic Method for Detection and Quantification of Psilocybin and Psilocin in Psilocybe cubensis MushroomsACS Omega · 2025-07-22Stronger visual surround suppression under psilocybin: A psychophysical and EEG pilot studyJournal of Vision · 2025-07-15Visual Hallucinations in Serotonergic Psychedelics and Lewy Body DiseasesPsyArXiv · 2025-07-15Behavioural and pharmacological evaluation of the psilocybin analogue baeocystin in Wistar rats.Progress in neuro-psychopharmacology & biological psychiatry · 2025-07-13Psilocybin treatment extends cellular lifespan and improves survival of aged mice.npj aging · 2025-07-08Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trial.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2025-07-01Psilocybin increases emotional empathy in patients with major depression.Molecular psychiatry · 2025-06-01Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic review.Neuroscience and biobehavioral reviews · 2025-06-01Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models.Neuroscience and biobehavioral reviews · 2025-05-01Psilocybin and ketamine affect novel neuropeptides gene expression in the rat hypothalamus.Journal of psychopharmacology (Oxford, England) · 2025-05-01Can the gut-brain axis provide insight into psilocybin's therapeutic value in reducing stress?Neurobiology of stress · 2025-05-01595. Psilocybin-Assisted Therapy for Relapse Prevention in Alcohol Use Disorder: A RCTBiological Psychiatry · 2025-04-09Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trialUniversität Zürich, ZORA · 2025-04-01Pharmacokinetics of Psilocybin: A Systematic Review.Pharmaceutics · 2025-03-25Extraction Yields of Psilocybin and Psilocin: A Short Review of Current Methods and Their ImplicationsPharmaceuticals · 2025-03-07Risks of using psilocybin in treatment of treatment-resistant depressionJournal of Education Health and Sport · 2025-03-06Prevalence and Correlates of Lifetime Ecstasy/MDMA Use Among Asian American and Pacific Islander Adult Populations in the United States, 2015-2020.Journal of psychoactive drugs · 2025-03-03Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder.The Journal of clinical psychiatry · 2025-03-03The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.Journal of affective disorders · 2025-03-01Correction: Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc AnalysisClinical Pharmacokinetics · 2025-03-01Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II Disorder.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01Psychedelics and Suicide-Related Outcomes: A Systematic Review.Journal of clinical medicine · 2025-02-20BEHAVIORAL PHENOTYPING AND METABOLOMIC COMPARISON OF CHEMICALLY SYNTHESIZED PSILOCYBIN AND PSYCHEDELIC MUSHROOM EXTRACT IN A ZEBRAFISH DEPRESSION MODELThe international journal of neuropsychopharmacology · 2025-02-01DETERMINATION OF TRYPTAMINE ALKALOIDS AND THEIR STABILITY IN PSYCHOTROPIC MUSHROOMSThe International Journal of Neuropsychopharmacology · 2025-01-31Single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - A first-in-kind open-label pilot study.Journal of affective disorders · 2025-01-15Quantitative LC-QToF-MS Analysis of Mycochemicals in Amanita muscaria, Psilocybe spp. (Agaricomycetes), and Consumer Products.International journal of medicinal mushrooms · 2025-01-01Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health Conditions.The American journal of psychiatry · 2025-01-01Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc AnalysisClinical Pharmacokinetics · 2025-01-01An investigation of acute physiological and psychological moderators of psychedelic-induced personality change among healthy volunteers.Neuroscience applied · 2025-01-01Psilocybin-assisted massed cognitive processing therapy for chronic posttraumatic stress disorder: Protocol for an open-label pilot feasibility trial.PloS one · 2025-01-01Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.Cureus · 2025-01-01Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.Cureus · 2025-01-01Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreat.Frontiers in psychiatry · 2025-01-01Informed Consent Documents from Psychedelic Clinical Trials: A Descriptive Ethical Analysis.AJOB empirical bioethics · 2025-01-01Impact of psilocybin on cognitive function: A systematic review.Psychiatry and clinical neurosciences · 2024-12-01Amid magic and menace: psychiatrists' attitudes to psilocybin therapy.Irish journal of psychological medicine · 2024-11-07Enhanced visual contrast suppression during peak psilocybin effects: Psychophysical results from a pilot randomized controlled trial.Journal of vision · 2024-11-04Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, pilot clinical trialPsyArXiv · 2024-11-04Psychedelics as a tool for a more connected and sustainable world? Considering the importance of rituals, boundaries, and commitment.The International journal on drug policy · 2024-11-01Optimized psilocybin production in tryptophan catabolism-repressed fungi.Microbial biotechnology · 2024-11-01“The mushroom was more alive and vibrant”: Patient reports of synthetic versus organic forms of psilocybinJournal of Psychedelic Studies · 2024-10-29Rapid and Prolonged Antidepressant and Antianxiety Effects of Psychedelics and 3,4-Methylenedioxy-methamphetamine-A Systematic Review and Meta-AnalysisPsychoactives · 2024-10-03Psilocybin in pharmacotherapy of obsessive-compulsive disorder.Pharmacological reports: PR · 2024-10-01The Epidemiology of Psychedelic Use Among United States Military VeteransJournal of Psychoactive Drugs · 2024-09-12Neural Mechanisms of Resting-State Networks and the Amygdala Underlying the Cognitive and Emotional Effects of Psilocybin.Biological psychiatry · 2024-07-01The influence of psilocybin on subconscious and conscious emotional learning.iScience · 2024-06-21THU-285 Lownonpsychedelic dosed of psilocybin for the therapy of MASLDJournal of Hepatology · 2024-05-31Comparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and Meditation.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2024-05-01National and regional trends in seizures of shrooms (psilocybin) in the United States, 2017-2022.Drug and alcohol dependence · 2024-05-01The 'PSILAUT' protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybin.BMC psychiatry · 2024-04-25A pilot study of the effect of group-administered psilocybin on psychological flexibility and outcomesJournal of Psychedelic Studies · 2024-04-05A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review.Journal of affective disorders · 2024-04-01Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin.Med (New York, N.Y.) · 2024-03-08Development of a digital intervention for psychedelic preparation (DIPP).Scientific reports · 2024-02-19Non-psychedelic doses of psilocybin as a novel therapeutic approach for MASLDDigestive and Liver Disease · 2024-02-01Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: An interpretive phenomenological analysis.Psychology of addictive behaviors: journal of the Society of Psychologists in Addictive Behaviors · 2024-02-01Social acceptability of psilocybin-assisted therapy for existential distress at the end of life: A population-based survey.Palliative medicine · 2024-02-01Enhanced visual contrast suppression during peak psilocybin effects: A psychophysical studyPsyArXiv · 2024-01-11Rapid-acting antidepressant drugs modulate affective bias in rats.Science translational medicine · 2024-01-10Associations between behavioral and neuronal changes in self-referential processing following a single, moderate dose of psilocybin in depressed patientsNeuroscience Applied · 2024-01-01Exploring the molecular basis of treatment-resistant depression: Discoveries from a rat model and psilocybin therapyNeuroscience Applied · 2024-01-01Must Psilocybin Always "Assist Psychotherapy"?The American journal of psychiatry · 2024-01-01Psychological Support for Psilocybin Treatment: Reply to Letters on Our Commentary.The American journal of psychiatry · 2024-01-01The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.Current neuropharmacology · 2024-01-01Valuing the Acute Subjective Experience.Perspectives in biology and medicine · 2024-01-01Amygdala response to emotional faces following acute administration of psilocybin in healthy individuals.Neuroscience applied · 2024-01-01Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms.Neuroscience applied · 2024-01-01Study protocol for "Psilocybin in patients with fibromyalgia: brain biomarkers of action".Frontiers in psychiatry · 2024-01-01Seasonal Variation of Use of Common Psychedelics and Party Drugs Among Nightclub/Festival Attendees in New York City.Journal of psychoactive drugs · 2024-01-01Prospective Preference Assessment for the Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN (PEACE-PAIN) Trial.Canadian journal of pain = Revue canadienne de la douleur · 2024-01-01Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine use.Frontiers in psychiatry · 2024-01-01Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model.Psychological medicine · 2023-12-01Hallucinogen use among young adults ages 19-30 in the United States: Changes from 2018 to 2021.Addiction (Abingdon, England) · 2023-12-01Potential use of psilocybin drugs in the treatment of depression.Expert opinion on emerging drugs · 2023-12-01Development of a Digital Intervention for Psychedelic Preparation (DIPP): a theory- and person-centred approachPsyArXiv · 2023-11-22Investigation of the structure, stability, and relative solubility of psilocybin in water and pure organic solvents: A molecular simulation studyJournal of Molecular Liquids · 2023-11-07Extended difficulties following the use of psychedelic drugs: A mixed methods studyPLoS ONE · 2023-10-23Psilocybin-induced changes in cerebral blood flow are associated with acute and baseline inter-individual differences.Scientific reports · 2023-10-14CROSS-SPECIES EVIDENCE FOR PSILOCIN-INDUCED VISUAL HALLUCINATIONS: RATS PERCEIVE QUALITATIVELY SIMILAR CHANGES AS HUMANSIBRO Neuroscience Reports · 2023-10-01Classic Psychedelics for the Treatment of Depressive Disorders: An Update for Psychiatrists in TrainingAmerican Journal of Psychiatry Residents Journal · 2023-09-08Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2023-09-01Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats.Molecular psychiatry · 2023-09-01Psilocybin decelerates cellular senescenceResearch Square · 2023-06-27Psychedelics, Meaningfulness, and the "Proper Scope" of Medicine: Continuing the Conversation.Cambridge quarterly of healthcare ethics: CQ: the international journal of healthcare ethics committees · 2023-06-27Psychedelics promote plasticity by directly binding to BDNF receptor TrkB.Nature neuroscience · 2023-06-01TMS-EEG and resting-state EEG applied to altered states of consciousness: oscillations, complexity, and phenomenology.iScience · 2023-05-19THE THERAPEUTIC POTENTIAL OF PSYCHEDELICS FOR MENTAL HEALTH DISORDERS: A REVIEW OF CURRENT EVIDENCEPARIPEX-INDIAN JOURNAL OF RESEARCH · 2023-05-15The Need for Psychiatric Treatment among Polish Users of Psychoactive Substances Is Increasing: This and Other Results from the Newest PolDrugs Survey.Medicina (Kaunas, Lithuania) · 2023-05-09Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.Journal of affective disorders · 2023-04-14Discovering the Potential Mechanisms of Medicinal Mushrooms Antidepressant Activity: A Review.Antioxidants (Basel, Switzerland) · 2023-03-02Considerations in assessing the abuse potential of psychedelics during drug development.Neuropharmacology · 2023-02-15Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial.EClinicalMedicine · 2023-02-01Conformational Landscape and Hydrogen Bonding Pattern of Psilocin: Computational InsightsChemistrySelect · 2023-01-09In Search of: A Federal Safe Harbor for State Legalization of PsilocybinLewis & Clark Law Review · 2023-01-01Psilocybin as a treatment for anorexia nervosa: 6-week and 3-month follow-up resultsNeuroscience Applied · 2023-01-01Extensive Collection of Psychotropic Mushrooms with Determination of Their Tryptamine Alkaloids.International journal of molecular sciences · 2022-11-15Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.The New England journal of medicine · 2022-11-03Interplay of hydrogen bonding in deciding the conformers of psilocin: Computational insightsAuthorea Preprints · 2022-09-01Psilocybin-Mediated Attenuation of Gamma Band Auditory Steady-State Responses (ASSR) Is Driven by the Intensity of Cognitive and Emotional Domains of Psychedelic Experience.Journal of personalized medicine · 2022-06-19Effects of psilocybin microdosing on awe and aesthetic experiences: a preregistered field and lab-based study.Psychopharmacology · 2022-06-01Psychedelic perceptions: mental health service user attitudes to psilocybin therapy.Irish journal of medical science · 2022-06-01SP56 Psychedelic drugs and painInvited speakers · 2022-05-31Effects of psilocybin in relative and global cerebral blood flow and behavioural correlatesNeuroscience Applied · 2022-01-01Investigating cue-reactivity as biomarker for treatment success in psilocybin-assisted therapy for alcohol use disorderNeuroscience Applied · 2022-01-01Raising awareness: The implementation of medical cannabis and psychedelics used as an adjunct to standard therapy in the treatment of advanced metastatic breast cancerDrug Science Policy and Law · 2022-01-01Rats hallucinate in a similar manner to humans after psilocinNeuroscience Applied · 2022-01-01Unravelling a New Conformer of Psilocin Through Computational MethodsSSRN Electronic Journal · 2022-01-01Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study.Journal of psychopharmacology (Oxford, England) · 2022-01-01The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.Journal of psychopharmacology (Oxford, England) · 2022-01-01Phenomenological assessment of psychedelics induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI).PloS one · 2022-01-01P.0553 Effect of chronic microdosing of psilocin on cell proliferation and behavior in ratsEuropean Neuropsychopharmacology · 2021-12-01Psilocybin Induces Aberrant Prediction Error Processing of Tactile Mismatch Responses-A Simultaneous EEG-FMRI Study.Cerebral cortex (New York, N.Y.: 1991) · 2021-11-23A Qualitative Exploration of Relational Ethical Challenges and Practices in Psychedelic HealingJournal of Humanistic Psychology · 2021-09-16Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders.Pharmacopsychiatry · 2021-07-01Registered clinical studies investigating psychedelic drugs for psychiatric disorders.Journal of psychiatric research · 2021-07-01Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analysesPsyArXiv · 2021-06-10Altered Prediction-Error Processing May Underlie Psilocybin-Induced Changes in Self-ProcessingBiological Psychiatry · 2021-04-27Phenomenological assessment of psychedelic induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI)PsyArXiv · 2021-04-02Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine.The Journal of neuroscience: the official journal of the Society for Neuroscience · 2021-02-03Stability of psilocybin and its four analogs in the biomass of the psychotropic mushroom Psilocybe cubensis.Drug testing and analysis · 2021-02-01Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.Frontiers in psychiatry · 2021-01-01P300-mediated modulations in self-other processing under psychedelic psilocybin are related to connectedness and changed meaning: A window into the self-other overlap.Human brain mapping · 2020-12-01Psilocybin Induces Time-Dependent Changes in Global Functional Connectivity.Biological psychiatry · 2020-07-15Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities.Journal of psychopharmacology (Oxford, England) · 2020-06-01Scoping Review Protocol: Mapping Psilocybin Animal ResearchQueen's University QSpace · 2020-05-20Binding Interactions of Psilocin and Serotonin in the 5-HT2A ReceptorVTechWorks (Virginia Tech) · 2020-05-05Direct Analysis of Psilocin and Muscimol in Urine Samples Using Single Drop Microextraction Technique In-Line with Capillary ElectrophoresisMolecules · 2020-03-29Can Psychedelics Radically Change SUD Treatment?Psychiatric News · 2020-03-20Rostral Anterior Cingulate Thickness Predicts the Emotional Psilocybin Experience.Biomedicines · 2020-02-18Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer.Journal of psychopharmacology (Oxford, England) · 2020-02-01Psilocybin's effects on the brain and implications for depression treatmentEpubl LTU · 2019-12-31Psychedelic microdosing benefits and challenges: an empirical codebook.Harm reduction journal · 2019-07-10Psilocybin-Assisted Therapy: A Double-Blind Randomized Controlled TrialYale School of Medicine Physician Associate Program Thesis · 2019-01-01Effects of psilocybin on functional connectivity measured with fNIRS: Insights from a single-subject pilot studyMatters · 2019-01-01Microdosing Psychedelics: Personality, mental health, and creativity differences in microdosersPsyArXiv · 2018-11-021.13 Microdosing of Hallucinogens Among College Students: Frequency, Correlates, and ConsequencesJournal of the American Academy of Child & Adolescent Psychiatry · 2018-09-30Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination.European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology · 2018-06-01Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors.Journal of psychopharmacology (Oxford, England) · 2018-01-01Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow.NeuroImage · 2017-10-01Effect of Psilocybin on Empathy and Moral Decision-Making.The international journal of neuropsychopharmacology · 2017-09-01Simultaneous determination of γ-hydroxybutyric acid, ibotenic acid and psilocybin in saliva samples by capillary electrophoresis coupled with a contactless conductivity detectorAnalytical Methods · 2017-01-01LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation.Frontiers in pharmacology · 2017-01-01Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.Journal of psychopharmacology (Oxford, England) · 2016-12-01Psilocybin-induced decrease in amygdala-putamen coupling during an event-related face discrimination taskEuropean Neuropsychopharmacology · 2016-10-01Effects of serotonin 2A/1A receptor stimulation on social exclusion processing.Proceedings of the National Academy of Sciences of the United States of America · 2016-05-03Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience.European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology · 2016-04-01